Figure 2From: Circulating tumor cells in newly diagnosed inflammatory breast cancer Kaplan-Meier estimates of probabilities of progression-free survival, according to baseline circulating tumor cell count in patients with newly diagnosed inflammatory breast cancer. Back to article page